Quinovare Medical Technology Co., Ltd., a China-based specialist in needle-free injectors, has announced a strategic partnership with AIM Vaccine Co., Ltd. (HKG: 6660) to enhance the accessibility and affordability of vaccines through their combined resources and expertise. Financial terms of the collaboration were not disclosed.
AIM Vaccine is a major player in the vaccine industry, operating a comprehensive supply chain across 31 provinces, autonomous regions, and municipalities in China. The company has a robust pipeline that includes eight commercialized vaccines and 23 in the investigational stage. Quinovare, on the other hand, is recognized for having the world’s largest and most advanced automated production line for needle-free injection drug delivery devices.- Flcube.com
